Chinese & European Healthcare

While China and Germany are both leaders in healthcare, they have progressed to this point in their own respective ways. The former with treatment of the masses through online hospitals, e-pharmacies, and the digitization of the entire healthcare system. The latter with technological breakthroughs and medical innovations such as with Bayer’s digitalization of drug discovery and BioNTech’s pioneering of immunotherapy for cancer and other serious diseases, not to mention the development of the first vaccine against COVID-19.

 

 

 

 


One of China’s largest providers of e-health services is AliHealth, a subsidiary of the Alibaba Group. Currently, AliHealth has over 39,000 contracted medical professionals as part of their team of online consultations. This means that Chinese citizens may effortlessly and quickly make appointments and receive treatment through their phones or computers. Germany, on the other hand, is still rolling out provisions in developing their e-healthcare network. 

While the foundations of government regulation and funding have already been laid, there is still the hurdle of lead time in which institutions will take in adjusting and adapting towards this new world of healthcare. Thus, in the meantime, Germany will continue advancing in major health-science related breakthroughs and innovations. 

 

 

 

 

 

 

 

 

 

 


Although it is clear that these two nations have distinct differences in their paths of healthcare development neither is superior than the other. Rather, they are representative of the needs of each country and their people. Fortunately, the knowledge can be shared between the two as a means towards a stronger and healthier future. 
 
Do you think e-health is a necessity in Germany and are the German people ready for such a change?

daniel-schludi-mAGZNECMcUg-unsplash.jpg
national-cancer-institute-NFvdKIhxYlU-unsplash.jpg